Trial Profile
A phase II study of Taxotere [docetaxel] and irinotecan (CPT-11) in patients with advanced adenocarcinoma of the lower esophagus, esophagogastric junction, and gastric cardia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2010
Price :
$35
*
At a glance
- Drugs Docetaxel (Primary) ; Irinotecan (Primary)
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 07 Sep 2006 Status change
- 23 Sep 2005 New trial record.